News - Ranbaxy Laboratories, Licensing

Filter

Popular Filters

Ranbaxy in deal with Alembic to market bioequivalent Pristiq in USA

05-03-2013

The US subsidiary of India's largest drugmaker, Ranbaxy Laboratories (AB: BO), which is majority owned…

Alembic PharmaceuticalsDaiichi SankyoGenericsLicensingMarkets & MarketingNeurologicalNorth AmericaPatentsPfizerPristiqRanbaxy Laboratories

Gilead partners to provide low-cost emtricitabine-based ARVs in developing countries

03-08-2012

Gilead Sciences (Nasdaq: GILD), together with Mylan Laboratories, Ranbaxy Laboratories and Strides Arcolab…

Anti-viralsBiotechnologyEmtricitabineGilead SciencesGlobalLicensingMylan LaboratoriesPharmaceuticalPricingProductionRanbaxy LaboratoriesStrides Arcolab

Back to top